Cargando…

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels

BACKGROUND: Many HIV-1-infected patients on suppressive antiretroviral therapy (ART) have transiently elevated HIV RNA levels. The clinical significance of these viral blips is uncertain. We have determined the incidence of blips and investigated important associations in the Swedish HIV-cohort. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sörstedt, Erik, Nilsson, Staffan, Blaxhult, Anders, Gisslén, Magnus, Flamholc, Leo, Sönnerborg, Anders, Yilmaz, Aylin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915053/ https://www.ncbi.nlm.nih.gov/pubmed/27329293 http://dx.doi.org/10.1186/s12879-016-1628-6

Ejemplares similares

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients
por: Flamholc, Leo, et al.
Publicado: (2008)

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
por: Albert, Jan, et al.
Publicado: (2014)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2021)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2022)

Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023)

1573. Viral Blips While on Antiretroviral Therapy are Associated with Virologic Failure
por: Fleit, Madeline, et al.
Publicado: (2023)

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
por: Vesterbacka, Jan, et al.
Publicado: (2013)

1584. Retrospective Study Comparing the Rate of HIV Blips With Combined Antiretroviral Therapy
por: Makhoul, Jennifer, et al.
Publicado: (2023)

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
por: Elvstam, Olof, et al.
Publicado: (2017)

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence
por: Darwish, Ilyse, et al.
Publicado: (2021)

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011)

Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90‐90‐90 continuum of HIV care targets
por: Gisslén, M, et al.
Publicado: (2016)

Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study
por: Farmer, Aaron, et al.
Publicado: (2016)

The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
por: Tyrberg, Erika, et al.
Publicado: (2022)

A blip, but a very big blip, in test of atom-smasher
Publicado: (2008)

A blip, but a very big blip, in test of atom-smasher
Publicado: (2008)

Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study
por: Brännström, Johanna, et al.
Publicado: (2016)

Reduction of the HIV-1 reservoir in resting CD4(+ )T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
por: Lindkvist, Annica, et al.
Publicado: (2009)

A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden
por: Brännström, J, et al.
Publicado: (2010)

Blood–brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV
por: Anesten, Birgitta, et al.
Publicado: (2016)

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
por: Cooper, C, et al.
Publicado: (2015)

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
por: Edén, Arvid, et al.
Publicado: (2016)

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
por: Gisslén, Magnus, et al.
Publicado: (2011)

Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia
por: Telele, Nigus Fikrie, et al.
Publicado: (2018)

Brookhaven: BLIP and CLIF and MEIN
Publicado: (1976)

A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
por: Conway, Jessica M., et al.
Publicado: (2011)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

1713. Factors Associated with Viral Rebound post Blip in Patients from a Community HIV Clinic
por: Sanchez, Eduardo, et al.
Publicado: (2020)

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
por: Neogi, Ujjwal, et al.
Publicado: (2017)

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
por: Neogi, Ujjwal, et al.
Publicado: (2014)

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014
por: Häggblom, Amanda, et al.
Publicado: (2017)

Viral Blips Were Infrequent in HIV-1-Infected Virologically-Suppressed Adults Treated with Tenofovir Alafenamide or Tenofovir DF Rilpivirine-Containing Regimens
por: Wohl, David A, et al.
Publicado: (2017)

Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
por: Rong, Libin, et al.
Publicado: (2009)

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection
por: Fidler, Sarah, et al.
Publicado: (2017)

1561 The Relationship Between Self-reported Adherence and Efavirenz Blood Levels on the Appearance of HIV Viral Load Blips
por: Farmer, Aaron, et al.
Publicado: (2014)

Higher plasma drug levels in elderly people living with HIV treated with darunavir
por: Tyrberg, Erika, et al.
Publicado: (2021)

Brookhaven : BLIP, CLIF et MEIN
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_to869modubo5ti3ued5vsdvs65